Title: Massive hypertriglyceridemia associated with paclitaxel; a case report
Authors: Koneshamoorthy, A
Hulse, D
Chong, CY
Krishnamurthy, B
Ananda, S
Hamblin, PS
Issue Year: 2022
Publisher ELSEVIER SCIENCE INC
Series GYNECOLOGIC ONCOLOGY REPORTS:
Abstract This report describes a patient who developed massive hypertriglyceridemia (12,488 mg/dL or 141 mmol/L) during paclitaxel and carboplatin adjuvant chemotherapy for high grade serous fallopian tube carcinoma. Paclitaxel was thought to be the causative agent and she had normal triglyceride levels following a change to carboplatin and gemcitabine. To our knowledge, this is the highest reported triglyceride level associated with paclitaxel. Measurement of serum lipids should be considered in individuals receiving taxane chemotherapy, especially in those with type 2 diabetes mellitus or a history of dyslipidemia.
URI: https://publications.svi.edu.au/publications/8530
Other Identifiers 10.1016/j.gore.2022.101030
Publication type Article